SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001044321-09-000179
Filing Date
2009-08-03
Accepted
2009-08-03 17:06:43
Documents
1
Group Members
AUSTIN W. MARXEAWM INVESTMENT COMPANY, INC.DAVID M. GREENHOUSELS ADVISERS LLCMG ADVISERS LLCMGP ADVISERS LIMITED PARTNERSHIPSPECIAL SITUATIONS FUND III QP, L.P.SPECIAL SITUATIONS LIFE SCIENCES FUND, L.P.SPECIAL SITUATIONS PRIVATE EQUITY FUND, L.P.

Document Format Files

Seq Description Document Type Size
1 cycc13d.txt SC 13D 9524
  Complete submission text file 0001044321-09-000179.txt   11982
Mailing Address C/O SPECIAL SITUATIONS FUNDS 527 MADISON AVENUE, SUITE 2600 NEW YORK NY 10022
Business Address C/O SPECIAL SITUATIONS FUNDS 527 MADISON AVENUE, SUITE 2600 NEW YORK NY 10022 2122076500
MARXE AUSTIN W & GREENHOUSE DAVID M (Filed by) CIK: 0001044321 (see all company filings)

IRS No.: 000000000
Type: SC 13D

Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Subject) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-80136 | Film No.: 09980880
SIC: 2834 Pharmaceutical Preparations